Japan, UAE Nations Sign Medical Tourism MOIs Centered On Technology
This article was originally published in PharmAsia News
Medical Excellence Japan and seven UAE members have signed memoranda of understanding encouraging medical tourism treatments in Japan to take advantage of the nation's medical technology, primarily endoscopy.
You may also be interested in...
Industry experts expect a continued uptick in deals valued between $2bn-$10bn this year as buyers look to add critical mass in areas like oncology, rare disease and cell and gene therapy. Divestitures to free up capital and narrow focus should continue too.
UK-centric investment firm Syncona’s model of “founding, building and funding” early-stage biotech companies – with a commitment to the longer term – hopes to help make Great Britain a cell and gene therapy powerhouse.
As part of its response to the coronavirus outbreak, Medicines for Europe has set out a series of policy recommendations that it says could help to mitigate the risks of COVID-19.